Meridiem Investment Management Ltd. - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 123 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
Meridiem Investment Management Ltd. ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2023$29,834
-13.4%
5750.0%0.00%0.0%
Q2 2023$34,454
+21.1%
5750.0%0.00%0.0%
Q1 2023$28,445
-13.3%
5750.0%0.00%0.0%
Q4 2022$32,818
+21.5%
5750.0%0.00%0.0%
Q3 2022$27,000
+28.6%
5750.0%0.00%0.0%
Q2 2022$21,000
+23.5%
5750.0%0.00%
Q1 2022$17,000
-15.0%
5750.0%0.00%
Q4 2021$20,0005750.00%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q2 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$29,942,30435.70%
RTW INVESTMENTS, LP 6,096,387$316,402,4856.68%
Paradigm Biocapital Advisors LP 1,384,686$71,865,2034.88%
Rock Springs Capital Management LP 2,943,710$152,778,5494.09%
Logos Global Management LP 450,000$23,355,0003.12%
TANG CAPITAL MANAGEMENT LLC 405,600$21,050,6402.97%
GREAT POINT PARTNERS LLC 290,917$15,098,5922.75%
Nicholas Investment Partners, LP 512,855$26,617,1751.99%
Eschler Asset Management LLP 30,000$1,557,0001.82%
COWEN AND COMPANY, LLC 460,036$23,875,8681.67%
View complete list of IMMUNOCORE HLDGS PLC shareholders